Patient Monitoring & Respiratory Care
Posted on: 15th April 2020
For over a decade IDR Medical has been working with leading patient monitoring and respiratory care companies to gather market insights that shape new products and drive commercial success.
Patient monitoring devices are essential in clinical decision making, with staff dependent on alerts and early detection to minimize poor outcomes. This is especially crucial given the current shift towards value-based care.
Our experience spans patient monitoring technologies across a broad patient population; from basic screening and triage to complex surveillance in critical care. Our projects in this market have related to current use and perceptions of products and brands, defining new concepts as well as understanding pain points in the workflow to explore new product and service opportunities.
IDR Medical have also helped clients understand potential opportunities in moving away from traditional business models based on capital investments to subscription base models where the vendor maintains ownership of all existing and future hardware, software, and networking solutions and provides servicing and support to drive efficiencies and improve quality of care.
The diseases which pulmonologists and respiratory care specialists attempt to fight are among the most common conditions in the modern world. According to WHO estimates, 235 million people suffer from asthma, 64 million live with chronic obstructive pulmonary disease (COPD). Other chronic diseases, such as bronchitis, emphysema, bronchiectasis and cystic fibrosis embitter the life of millions more.
Over the past 12 years IDR Medical have worked closely with leading industry players in respiratory care, including manufacturers of hospital and home ventilators, sleep apnea solutions, oxygen therapy, drug delivery devices and innovative pharmaceuticals. Our team is uniquely positioned in these markets with research capabilities and market knowledge that extend across diseases, care environments, diagnostic and therapeutic interventions.